BioXcel Therapeutics Inc (BTAI)
2.61
-0.10
(-3.69%)
USD |
NASDAQ |
Apr 25, 16:00
2.63
+0.02
(+0.77%)
Pre-Market: 09:09
BioXcel Therapeutics Profit Margin (Quarterly): -5.92K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.92K% |
| September 30, 2023 | -14.81K% |
| June 30, 2023 | -11.71K% |
| Date | Value |
|---|---|
| March 31, 2023 | -25.63K% |
| December 31, 2022 | -23.03K% |
| September 30, 2022 | -30.51K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-30.51K%
Minimum
Sep 2022
-5.92K%
Maximum
Dec 2023
-18.60K%
Average
-18.92K%
Median
Profit Margin (Quarterly) Benchmarks
| Synlogic Inc | -524.9% |
| Cormedix Inc | -- |
| Bristol-Myers Squibb Co | 15.35% |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | -197.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.32K% |
| Return on Assets | -127.9% |
| Return on Invested Capital | -171.1% |
| Gross Profit Margin (Quarterly) | -89.89% |
| Operating Margin (Quarterly) | -5.29K% |
| Return on Net Operating Assets | -2.33K% |